(Q38440869)

English

Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

0 references

anti-retroviral agent

0 references

6

object named as

Mona R Loutfy

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sharon Walmsley

3

object named as

Sharon Walmsley

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Janet Raboud

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sandra Blitz

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Courtney Thompson

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sean B Rourke

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Ontario HIV Treatment Network Cohort Study Team

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

340-350

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Does patient sex affect human immunodeficiency virus levels?

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Improvements in antiretroviral therapy outcomes over calendar time

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Medicinal and recreational marijuana use by patients infected with HIV.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Gender difference in HIV-1 RNA viral loads

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Gender Differences in HIV-1 RNA Rebound Attributed to Incomplete Antiretroviral Adherence Among HIV-Infected Patients in a Population-Based Cohort

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Plasma Viral Load Concentrations in Women and Men From Different Exposure Categories and With Known Duration of HIV Infection

1 reference

https://api.crossref.org/works/10.1310%2FHCT1106-340

21 January 2018

Identifiers

10.1310/HCT1106-340

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38440869&oldid=1878991308"